Sigmoid Pharma Completes Phase II Trial of CyCol™ in More than 100 Ulcerative Colitis Patients and Raises €3 Million

DUBLIN--(BUSINESS WIRE)--Sigmoid Pharma Ltd. (Sigmoid), a privately-owned, specialty pharmaceutical and drug delivery company registered in Ireland, today provides an update on significant progress in 2011 and 2012. Sigmoid’s AGM takes place today at 5 pm GMT